Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)
Clinical trial NCT02564380 · TERMINATED
Trial details
- NCT number
- NCT02564380
- Sponsor
- AIO-Studien-gGmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-19
- Primary completion
- 2020-05-23
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.